Pioneering innovation through the immune system
Cugene (cugene.com) scores 70 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 24th percentile of 8842 Healthcare brands.
Cugene is a Boston-based clinical-stage biotechnology company focused on developing next-generation immune-modulating biologics to treat cancer and autoimmune diseases. The company combines immunology expertise with precision protein engineering to create therapeutics targeting T cells, antigen presenting cells, and macrophages. Its work is aimed at restoring immune balance in patients, and it engages with pharmaceutical partners, investors, and the broader biotech and medical research community as part of its development and commercialization efforts.
| Brand Name | Cugene |
|---|---|
| Domain | cugene.com |
| Industry | Healthcare |
| Headquarters | Boston, Massachusetts |
| Main Competitors | Cue Biopharma (72/100), Synthekine (72/100), Werewolf Therapeutics (71/100), Asher Biotherapeutics (74/100), Compugen (82/100), Cullinan Oncology (69/100), Sonoma Biotherapeutics |
Moz Domain Authority 19/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Cugene" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 4 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Cugene?", Claude could identify the brand as of September 2026. Cugene is a clinical-stage biopharmaceutical company that develops engineered cytokine therapies aimed at treating cancer and autoimmune diseases, using protein engineering to improve the safety and efficacy profile of cytokines compared to earlier generations. Best known for engineering novel cytokine-based immunotherapies for oncology and autoimmune conditions.
When asked "Best brands similar to Cugene?", Claude would not surface Cugene as of September 2026. It's a relatively early-stage, niche biotech that wouldn't typically come up unless someone specifically asked about cytokine engineering companies rather than broader healthcare brands.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cugene's main competitors in Healthcare: Cue Biopharma (72/100), Synthekine (72/100), Werewolf Therapeutics (71/100), Asher Biotherapeutics (74/100), Compugen (82/100).
Sources: Brand Analyzer scan
Cugene is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. It develops next-generation biologics-based therapeutics designed to harness and modulate the human immune system to treat cancer and autoimmune diseases.
Sources: Cugene official site
Cugene has low AI-search visibility, scoring 22/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 37, recommendation 42). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cugene official site
Cugene develops immune-modulating biologic therapeutics by combining immunology expertise with precision protein engineering. Its research targets specific immune cell types-T cells, Antigen Presenting Cells, and Macrophages-to create treatments intended to restore immune balance in patients with cancer or autoimmune conditions.
Sources: Cugene official site
Cugene scores 42/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Cugene official site
Cugene can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cugene official site
Cugene offers biologics-based therapeutic candidates developed through its immunology and protein engineering platform, targeting T cells, Antigen Presenting Cells, and Macrophages for the treatment of cancer and autoimmune diseases. As a clinical-stage company, its offerings are primarily investigational drug candidates rather than commercially available products.
Sources: Cugene official site
Cugene is known for its technology platform that integrates deep immunology expertise with precision protein engineering to design biologics targeting T cells, Antigen Presenting Cells, and Macrophages, aimed at treating cancer and autoimmune diseases.
Sources: Cugene official site
Cugene's therapeutics are intended for patients suffering from cancer and autoimmune diseases. The company also engages with pharmaceutical partners, investors, and members of the biotech and medical research community who support or collaborate on its drug development programs.
Sources: Cugene official site
Cugene scores 22/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cugene has a weak AI-visibility profile at 22/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (42/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 19/100. In a live check, Claude could already identify Cugene from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Cugene: Croma-Pharma (70/100), Crestwood Medical Center (70/100), Curvo (70/100), CXT Software (70/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.